Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Fighting The Challenges Of Poverty
It is estimated that 1.4 billion people live in extreme poverty, on less than $2 a day. In 2000, 189 nations declared that they would "free all men, women, and children from the abject and dehumanizing conditions of extreme poverty". These nations signed up to Millennium Development Goals (MDGs) to combat poverty by 2015. To help meet these complex challenges and "make poverty history" more knowledge and evidence is needed. A launch event Wednesday 22nd July 2009 at the Department for International Development (DFID) marks a new phase of research collaboration between the Economic and Social Research Council (ESRC) and DFID which will provide more robust social science research to address poverty alleviation amongst the poorest countries and peoples of the world.
generic viagra online
Xeloda In Combination With Oxaliplatin Shown To Be Effective In Early Colon Cancer
Roche announced results from the international phase III study NO16968 (XELOXA), investigating oral Xeloda in combination with intravenous oxaliplatin (XELOX) immediately after surgery, which show that patients with colon cancer taking XELOX live disease free for longer compared to those taking the commonly used intravenous chemotherapy combination 5-fluorouracil/leucovorin (5-FU/LV). The data prove that XELOX is superior to 5-FU/LV in terms of the time patients live without their cancer being detectable.
News of the day
Joint Meeting - American Academy Of Ophthalmology
The largest and most comprehensive ophthalmic educational meeting in the world, the American Academy of Ophthalmology"s (Academy) 2009 Joint Meeting in conjunction with the Pan- American Association of Ophthalmology (PAAO) will be taking place in San Francisco, Oct. 24 to 27.
Endocrinology

Cook Medical Announces FDA Clearance For Advance(R) 35LP PTA Balloon Dilatation Catheter

Cook Medical has received clearance from the U.S. Food and Drug Administration (FDA) to market its newest balloon dilatation catheter, the Advance® 35LP. The device is intended for use in patients with lesions in the femoral, iliac and renal arteries and rounds out Cook"s complete line of low-profile PTA balloons. The Advance 35LP will play an integral part in Cook"s Leg Therapy Program, an initiative geared toward helping physicians address the anatomical challenges of treating Peripheral Vascular Disease (PVD) and deliver clinically effective interventional solutions to the patients who need them most. Commonly associated with diabetes, hypertension and coronary disease, PVD can result in amputation or death if left untreated. Few are aware of the minimally invasive treatment options available apart from amputation or surgical bypass, the latter of which is the current gold standard in treating this disease. The Advance line comprises three low-profile balloons (14LP, 18LP, 35LP) that range in size and composition to treat lesions in the peripheral arteries as well as obstructive lesions of native or synthetic arteriovenous dialysis fistulas. The Advance 35LP balloon, compatible with a .035-inch wire guide, is designed to address common above-the-knee blockages. The Advance 18LP, compatible with a .018-inch wire guide, is geared toward the femoral artery and popliteal region of the leg. The Advance 14LP, compatible with a .014-inch wire guide, is reserved for treatment of the most tortuous anatomies of the lower leg, including the popliteal and infrapopliteal arteries. Each balloon features a low crossing profile and small-sheath compatibility, which helps reduce the need for an invasive arterial entry and may shorten patient recovery time. Advanced thermal setting of the balloon folds improves rewrap and sheath pull-back, and a unique double-lumen shaft construction using optimized nylon-blend material reduces balloon inflation/deflation time and improves pushability while maintaining kink resistance. Cook Medical


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009